Form 4: Beauty Health Co. CSO/COO Lewis Granted RSUs

Beauty Health Company's CSO and COO, Sheri Lewis, was granted 746,681 restricted stock units, vesting over three years.

Summary

• Sheri Lewis, Chief Strategy Officer (CSO) and Chief Operating Officer (COO) of The Beauty Health Company, received a grant of 746,681 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of Class A Common Stock of The Beauty Health Company.
• The RSUs are subject to time-vesting conditions, with one-third vesting on each of the first three anniversaries of the grant date.
• The vesting is contingent upon continued service with the Company through each vesting date, with certain acceleration rights.
• Following this transaction, Sheri Lewis beneficially owns 1,609,524 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It represents a standard executive compensation practice that aligns management's interests with shareholders, without indicating any immediate operational or financial changes.

Positives

• The grant of restricted stock units aligns the interests of a key executive, Sheri Lewis, with those of shareholders, incentivizing long-term performance and retention.
• The vesting schedule over three years encourages sustained commitment and contribution from the CSO and COO.

Negatives

• The future issuance of shares upon vesting of the RSUs could lead to a minor dilutive effect on existing shareholders, although this is a standard component of executive compensation.

Risks

• The RSUs are subject to forfeiture if the reporting person's service with the Company ceases before the vesting dates, representing a risk to the executive's full realization of the grant.

Future Outlook

The vesting schedule of the RSUs over the next three years indicates an expectation of continued service and contribution from Sheri Lewis, a key executive, through at least March 2029.

Industry Context

StockSavvy.ai notes that the grant of restricted stock units to key executives is a common and widely accepted practice in publicly traded companies across various industries. This form of equity compensation is designed to align executive incentives with long-term shareholder value creation and promote executive retention.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) with time-based vesting is a standard component of executive compensation packages in the consumer discretionary and beauty industry, comparable to practices at companies like Estée Lauder (EL), L'Oréal (OR.PA), and Ulta Beauty (ULTA).
• The three-year vesting schedule is typical for such grants, providing a balance between immediate incentive and long-term commitment, consistent with global benchmarks for executive equity awards.

Stakeholder Impact

• Shareholders: The grant aligns executive incentives with shareholder interests, potentially leading to better long-term performance. However, it also implies future share dilution upon vesting.
• Employees: The grant to a senior executive may serve as a benchmark or incentive for other employees within the company's compensation structure.

Next Steps

• The RSUs will vest in one-third increments on March 20, 2027, March 20, 2028, and March 20, 2029, subject to continued service.

Key Dates

Keywords

Beauty Health Company, SKIN, Restricted Stock Units, RSU Grant, Executive Compensation, Insider Transaction, Sheri Lewis, CSO, COO, Form 4